Acetate from probiotics could prevent NAFLD-HCC progression by binding with G-coupled protein receptor 43 (GPR43) and suppressing the IL-6/JAK1/STAT3 signaling pathway (14). The gene discussed is FFAR2; the disease is metabolic dysfunction-associated steatotic liver disease.